Substance / Medication

Sotalol hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

12 trials linked to this intervention

12
Total Trials
1
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
Batra Gorav, Aktaa Suleman, Camm A John et al. · Eur Heart J Qual Care Clin Outcomes · 2023
PMID: 36243903Meta-AnalysisFull text (PMC)
Management of atrial flutter and atrial fibrillation with rapid ventricular response in patients with acute decompensated heart failure: A systematic review.
Niforatos Joshua D, Ehmann Michael R, Balhara Kamna S et al. · Acad Emerg Med · 2023
PMID: 36326565Meta-Analysis
Arrhythmias Beyond Atrial Fibrillation Detection Using Smartwatches: A Systematic Review.
Pay Levent, Yumurtaş Ahmet Çağdaş, Satti Danish Iltaf et al. · Anatol J Cardiol · 2023
PMID: 36856589Meta-AnalysisFull text (PMC)
Pharmacokinetics and electrophysiological effects of sotalol hydrochloride in horses.
Broux B, De Clercq D, Decloedt A et al. · Equine Vet J · 2018
PMID: 29023952RCT
HPLC and LC-MS/MS-Based Quantitative Characterization of Related Substances Associated with Sotalol Hydrochloride.
Zhu Pengyan, Shen Xiaojing, Wang Xinting et al. · Molecules · 2024
PMID: 38338332OtherFull text (PMC)
Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study.
Klovrzová Sylva, Zahálka Lukáš, Kříž Tomáš et al. · Eur J Hosp Pharm · 2016
PMID: 31156811OtherFull text (PMC)
[Determination of sotalol hydrochloride by reversed-phase high performance liquid chromatography].
Wang W H, Zhao G S, Jiang W L et al. · Se Pu · 2000
PMID: 12541604Other
Single- and multiple-dose pharmacokinetics of sotalol hydrochloride in healthy cats.
Salmon S J, Coleman A E, Lynn C R et al. · J Vet Cardiol · 2024
PMID: 38118234Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sotalol hydrochloride (substance)
SNOMED CT
125691000
UMLS CUI
C0026289

Clinical Data

This intervention maps to 12 entities in the Healos knowledge graph.

7
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
12
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.